Cervical sarcoma botryoides and ovarian Sertoli-Leydig cell tumor: a case report and review of literature

Arch Gynecol Obstet. 2012 Mar;285(3):845-8. doi: 10.1007/s00404-011-2017-4. Epub 2011 Aug 17.

Authors

P Rosenberg¹, S Carinelli, M Peiretti, V Zanagnolo, A Maggioni

Affiliation

¹ Unit of Gynecology, European Institute of Oncology, Via Ripamonti, 239, Milan, Italy. [email protected]

PMID: 21847587
DOI: 10.1007/s00404-011-2017-4

No abstract available

Publication types

Case Reports
Review

MeSH terms

Antineoplastic Agents / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Epirubicin / therapeutic use
Female
Humans
Ifosfamide / therapeutic use
Neoplasms, Multiple Primary / diagnosis*
Neoplasms, Multiple Primary / drug therapy
Neoplasms, Multiple Primary / surgery
Ovarian Neoplasms / diagnosis*
Ovarian Neoplasms / pathology
Ovarian Neoplasms / surgery
Prolactin / blood
Sarcoma / diagnosis*
Sarcoma / drug therapy
Sarcoma / pathology
Sarcoma / surgery
Sertoli-Leydig Cell Tumor / diagnosis*
Sertoli-Leydig Cell Tumor / pathology
Sertoli-Leydig Cell Tumor / surgery
Testosterone / blood
Treatment Outcome
Uterine Cervical Neoplasms / diagnosis*
Uterine Cervical Neoplasms / drug therapy
Uterine Cervical Neoplasms / pathology
Uterine Cervical Neoplasms / surgery
Young Adult

Substances

Antineoplastic Agents
Testosterone
Epirubicin
Prolactin
Ifosfamide